# A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer(PANKU-Breast01)

Source: https://onco.cc/trials/nct06343948/  
OnCo record `nct06343948` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Eribulin, Vinorelbine, Gemcitabine and Capecitabine in advanced solid tumours, run by Sichuan Baili Pharmaceutical Co., Ltd., active and no longer recruiting.

## Summary

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer(PANKU-Breast01) is a phase 3 interventional study registered as NCT06343948 by Sichuan Baili Pharmaceutical Co., Ltd., with 383 participants enrolled, started 2024-04-24 and due to reach its primary completion in 2026-08. Interventions recorded: BL-B01D1, Eribulin, Vinorelbine, Gemcitabine and Capecitabine.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06343948
- Phase: 3
- Setting: A Phase III Randomized Controlled Clinical Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer After Failure of at Least One Prior Line of Chemotherapy
- Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
- Enrolled: 383

## Sources

- ClinicalTrials.gov NCT06343948: https://clinicaltrials.gov/study/NCT06343948

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- drugs: [Capecitabine](https://onco.cc/drugs/capecitabine/), [Eribulin](https://onco.cc/drugs/eribulin/), [Gemcitabine](https://onco.cc/drugs/gemcitabine/), [Vinorelbine](https://onco.cc/drugs/vinorelbine/)
- companies: [SystImmune / Sichuan Biokin](https://onco.cc/companies/systimmune/)

---
JSON: https://onco.cc/api/v1/entities/nct06343948.json